For the treatment of IR, the currently used drug is metformin, which has been shown to improve the metabolic and clinical status of women with PCOS by reducing insulin levels, androgen levels, circulating free Testosterone levels, and increasing SHBG. The gene discussed is SHBG; the disease is polycystic ovary syndrome.